On June 7, 2018, Lin, Wenbin; He, Chunbai; Lu, Kuangda; Ni, Kaiyuan; Lan, Guangxu published a patent.Computed Properties of 1312703-30-2 The title of the patent was Nanoparticles for photodynamic therapy, x-ray induced photodynamic therapy, radiotherapy, radiodynamic therapy, chemotherapy, immunotherapy, and any combination thereof. And the patent contained the following:
Metal-organic frameworks (MOFs) comprising photosensitizers are described. The MOFs can also include moieties capable of absorbing X-rays or other ionizing irradiation energy and/or scintillation. Optionally, the photosensitizer or a derivative thereof can form a bridging ligand of the MOF. Further optionally, the MOF can comprise inorganic nanoparticles in the cavities or channels of the MOF or can be used in combination with an inorganic nanoparticle. Also described are methods of using MOFs and/or inorganic nanoparticles in photodynamic therapy, X-ray induced photodynamic therapy, radiotherapy, radiodynamic therapy, or in radiotherapy-radiodynamic therapy, either with or without the co-administration of one or more immunotherapeutic agent and/or one or more chemotherapeutic agent. The experimental process involved the reaction of Dimethyl 2′-amino-[1,1′:4′,1”-terphenyl]-4,4”-dicarboxylate(cas: 1312703-30-2).Computed Properties of 1312703-30-2
The Article related to mof photosensitizer nanoparticles photodynamic chemotherapy immunotherapy therapy cancer, Pharmaceuticals: Formulation and Compounding and other aspects.Computed Properties of 1312703-30-2
Referemce:
Ester – Wikipedia,
Ester – an overview | ScienceDirect Topics